![](/img/cover-not-exists.png)
Treating to a Target in Established Active Rheumatoid Arthritis Patients Receiving a Tumor Necrosis Factor Inhibitor: Results From a Real-World Cluster-Randomized Adalimumab Trial
Pope, Janet E., Haraoui, Boulos, Rampakakis, Emmanouil, Psaradellis, Eliofotisti, Thorne, Carter, Sampalis, John S.Volume:
65
Language:
english
Journal:
Arthritis Care & Research
DOI:
10.1002/acr.22010
Date:
September, 2013
File:
PDF, 165 KB
english, 2013